Veterinary Sedative Medetomidine Detected in Halifax Drug Supply, Complicating Overdose Response
Medetomidine, a veterinary sedative not approved for human use, has been found laced with fentanyl in Halifax's drug supply. The substance does not respond to naloxone and has contributed to drug toxicity deaths in Nova Scotia.
A veterinary sedative called medetomidine, which is not approved for human use, has been detected in Halifax's drug supply, often mixed with opioids such as fentanyl. Its presence has increased overdose risks because users are unaware they are consuming the substance, and it does not respond to naloxone, a common medication used to reverse opioid overdoses.

Data from the Medical Examiner Service confirms that medetomidine has already contributed to drug toxicity deaths in Nova Scotia. Sara Wuite, a harm reduction consultant with Nova Scotia Health, stated that the primary danger of medetomidine is that users do not know they are taking it.
Halifax Regional Police confirmed that medetomidine was present in a fentanyl sample seized during a search on Elmwood Avenue in Dartmouth on September 4. That seizure was part of the largest fentanyl seizure in Atlantic Canadian history.
Because medetomidine does not respond to naloxone, administering the reversal medication may fail to stop an overdose involving the substance. Users are advised to call 911 and perform rescue breathing if naloxone fails.

The Nova Scotia RCMP rely on Health Canada to test seized substances and could not confirm the exact number of samples containing medetomidine across the province.